Phelan-McDermid Syndrome 101
Quick links to important information for families and clinicians about neuropsychiatric regression in PMS.
NEW Quick Resource Cards
PMSF Releases the first in a series of Quick Resource Cards by Diane Linnehan, Director of Operations and Jenn Carter, Mom…
Neuropsychiatric Conditions in PMS
Quick links to important information for families and clinicians about neuropsychiatric regression in PMS.
PMS Medical Advisory; Catatonia and NMS
Important Message from our Medical Advisory Committee November 7, 2022 From: Alex Kolevzon, MD, PMS MAC chairperson; William Bennett, Jr, MD,…
Jaguar Gene Therapy Will Target SHANK3 for Gene Therapy
JAG201 is designed to address mutation or deletion of the SHANK3 gene, a leading autism candidate gene, by delivering SHANK3 gene replacement therapy.
PMSF Medical Advisory
The Phelan-McDermid Syndrome Foundation Medical Advisors Issue Guidance on Important Treatment Considerations for PMS Patients Our MAC recently issued two guidance documents…
Important Message From Our Medical Advisory Committee
The Phelan-McDermid Syndrome (PMS) Medical Advisory Committee would like to inform the patient community and the providers who care for them…